Skip to main content
Loading...
Menu social network
LinkedIn
Facebook
X
Youtube
Menu top
Assistance
User account menu
Log in
Main navigation
Home
Programme
Download the app
App
Download the app
App
Menu
Login
Close
Main navigation mobile
Home
Programme
Menu top
Assistance
Menu social network
LinkedIn
Facebook
X
Youtube
26 results
- D1.532 - Phenotypic and Functional Comparison of LAD2, HMC-1.2, and Primary Human Mast Cells
- D1.529 - Evaluating the Disease-Modifying Potential of Elenestinib, a Highly Potent and Selective Tyrosine Kinase Inhibitor, in Patients With Indolent Systemic Mastocytosis: An Update on the Pivotal HARBOR Study
- D1.530 - Patient Experience of Most Burdensome Nonadvanced Systemic Mastocytosis Symptoms From the Pivotal Summit Trial of Bezuclastinib
- D1.531 - Avapritinib in Indolent Systemic Mastocytosis: Real-world Data from a Greek Case Series
- D1.533 - Systemic mastocytosis despite normal baseline tryptase: a diagnostic pitfall in recurrent life-threatening anaphylaxis
- D1.536 - Immunological basis of coexisting slowly progressive insulin-dependent diabetes mellitus (SPIDDM) and Vogt–Koyanagi–Harada disease (VKH)
- D1.537 - Immunopharmacogenomics as a Systems Medicine Framework for Precision Therapy in Allergic and Immune Mediated Diseases
- D1.538 - First Report of the SERPING1 c.52-1G>A Variant in a Chinese HAE Pedigree: Severe Abdominal Phenotype Correlated with Attack-Phase Imaging
- D1.540 - Automated generation of real-world clinical databases in Allergy: a data-driven research framework
- D1.541 - Addressing Allergy undergraduate education: Strategic Reforms for Specialist-Led Allergy teaching in Medical Curricula. A EAACI Tailored Education Committee Task Force
D1.539 - Efficacy and safety of sotatercept in pulmonary arterial hypertension: a systematic review and meta‐analysis of randomized controlled trials
D2.245 - Dithranol loaded Dendritic nanoarchitectures for the treatment of psoriasis
D2.246 - Occupational contact dermatitis to chromium in guitarist
D2.247 - Vitamin D Status as a Modifiable Factor in Chronic Spontaneous Urticaria
D2.249 - The impact of the coronavirus infection and vaccination against SARS-CoV-2 in the course of chronic urticaria
D2.251 - Allergic Contact Dermatitis to Clonidine Transdermal Patch: Insights From a Rare Case With Prolonged Cutaneous Exposure
D2.254 - Thyroid Autoantibody Seroconversion in Chronic Spontaneous Urticaria: Insights from Omalizumab Treated Patients
D2.255 - Adult-onset Still’s disease mimicking chronic spontaneous urticaria: a case report
D2.259 - Beyond Contact with Water: A Case of Aquagenic Urticaria
D2.250 - Sensitivity to Dental Materials and Its Clinical Implications: A Retrospective Patch Test Study
Pagination
Current page
1
Page
2
Next page
Next
Last page
Last
Download the app
The congress at your fingertips
Available on
Download